Management of Recurrent UTIs in Patients with Foley Catheters
Introduction to Prevention Strategies
- The Infectious Diseases Society of America recommends removing the Foley catheter as soon as medically possible, as the length of catheterization is the primary risk factor for recurrent infections 1
- Reassess catheter necessity daily and remove within 48 hours if possible to avoid the exponentially increasing infection risk that occurs with prolonged catheterization, as suggested by the Infectious Diseases Society of America 1
Catheter Management
- Use silver alloy-coated urinary catheters rather than standard catheters, as meta-analysis demonstrates they significantly reduce UTI rates and may reduce overall costs despite higher upfront expense 2
- Maintain a closed drainage system at all times with the collection bag positioned below the level of the bladder to prevent retrograde bacterial migration, as recommended by the Infectious Diseases Society of America 1
- Avoid concomitant use of multiple urinary devices when feasible, according to the Ca-A Cancer Journal for Clinicians 4, 5
Infection Prevention and Treatment
- Do not use prophylactic antimicrobials routinely, as this increases antimicrobial resistance without proven benefit, which is a strong recommendation (A-I level evidence) from IDSA guidelines 1, 6
- Obtain urine culture before initiating treatment to guide antimicrobial selection, as recommended by the Journal of the American College of Radiology 10
- Replace the catheter before treating symptomatic UTI, as biofilms on the existing catheter harbor bacteria that are protected from antimicrobials, according to the Infectious Diseases Society of America 1
Alternative Methods and Long-Term Considerations
- Consider intermittent catheterization instead of indwelling catheters when feasible, as this significantly reduces infection risk, as suggested by the Stroke journal 2, 3
- Use chlorhexidine-impregnated dressings at the exit site with weekly exchanges for patients with frequent infections, according to the Ca-A Cancer Journal for Clinicians 4, 5